Tech Company Financing Transactions

Neurelis Funding Round

Neurelis, based in San Diego, raised $5.2 million from private investors.

Transaction Overview

Company Name
Announced On
Transaction Type
Proceeds Purpose
Proceeds purposes were not disclosed. 11 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.

Company Information

Company Status
Private & Independent
Mailing Address
3430 Carmel Mountain Rd. 300
San Diego, CA 92121
Email Address
Neurelis, Inc. is a specialty pharmaceutical company organized to license, develop, and commercialize product candidates for the treatment of central nervous system disorders with a focus on the treatment of acute breakthrough seizures (epilepsy) and acute anxiety episodes.
Neurelis LinkedIn Company Profile
Social Media
Neurelis Company Twitter Account
Company News
Neurelis News
Neurelis on Facebook
Neurelis on YouTube

Management Team

Email & Social
Chief Executive Officer
Craig Chambliss
  Craig Chambliss LinkedIn Profile  Craig Chambliss Twitter Account  Craig Chambliss News  Craig Chambliss on Facebook
Chief Financial Officer
George Stuart
  George Stuart LinkedIn Profile  George Stuart Twitter Account  George Stuart News  George Stuart on Facebook
Chief Medical Officer
Enrique Carrazana
  Enrique Carrazana LinkedIn Profile  Enrique Carrazana Twitter Account  Enrique Carrazana News  Enrique Carrazana on Facebook
Chief Scientific Officer
Stuart Madden
  Stuart Madden LinkedIn Profile  Stuart Madden Twitter Account  Stuart Madden News  Stuart Madden on Facebook
Vice President
Chuck DeWildt
  Chuck DeWildt LinkedIn Profile  Chuck DeWildt Twitter Account  Chuck DeWildt News  Chuck DeWildt on Facebook
Vice President
Adrian Rabinowicz
  Adrian Rabinowicz LinkedIn Profile  Adrian Rabinowicz Twitter Account  Adrian Rabinowicz News  Adrian Rabinowicz on Facebook
VP - Bus. Development
Thomas Liquard
  Thomas Liquard LinkedIn Profile  Thomas Liquard Twitter Account  Thomas Liquard News  Thomas Liquard on Facebook
VP - General Counsel
Jenny Alonso
  Jenny Alonso LinkedIn Profile  Jenny Alonso Twitter Account  Jenny Alonso News  Jenny Alonso on Facebook
VP - Marketing
Steve Jenner
  Steve Jenner LinkedIn Profile  Steve Jenner Twitter Account  Steve Jenner News  Steve Jenner on Facebook
VP - Regulatory Affairs
Edward Smith
  Edward Smith LinkedIn Profile  Edward Smith Twitter Account  Edward Smith News  Edward Smith on Facebook



Browse more venture capital transactions:

Prev: 8/27/2018: Evolve Vacation Rental Network venture capital transaction
Next: 8/28/2018: Harbour BioMed venture capital transaction


Share this article


Where The Data Comes From

We document all VC transactions involving tech companies. VC investment data records on this site come from news reports and company announcements. The data comes to us via our partnership with, an affiliated venture.


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities


Business Glossary